Evonik invests in company Vivasure Medical
Innovative Technology closes arteries: Evonik through its Venture Capital activities has invested in the Galway Ireland based medical device company Vivasure Medical Limited. The financing round was led by Netherlands based Life Science Partners Health Economics Fund and also joining the syndicate is Panakes Fund based in Milan Italy. Previous Vivasure investors from the med-tech space including Fountain Partners, Orchestra Medical Ventures and Ascent Biomedical Ventures are participating in the funding round as well.
"Solutions for health and medical technology are among the key growth areas for Evonik. Due to our technological competence in these areas and our existing product portfolio, Vivasure Medical fits strategically with Evonik", says Bernhard Mohr, Head of Venture Capital at Evonik. The Vivasure Closure Device is the first product from the company’s PerQseal™ technology platform, and is the only approved fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures. Worldwide these minimally invasive procedures are becoming prevalent in operations. In some areas they are already established as the standard. The reason: only small incisions are required to perform minimally invasive procedures, which are easier on patients.
"We are pleased to have Evonik, who can especially help us with its expertise in polymers for Pharma and Medical Device applications as a strategic partner," says Gerard Brett, Chief Executive Officer and one of the founders of Vivasure Medical. "The Vivasure closure device is designed to be easy to use, allowing the surgeon to provide a complete repair at the access site, without leaving metal implants, sutures, or exogenous tissue behind. Our goal is improved clinical outcomes, faster recovery times and better therapeutic results for patients over the open-surgery alternative.”
Vivasure Medical is utilizing RESOMER®, a bioabsorbable polymer from Evonik, which has already proved its value in numerous commercial applications. "The participation in Vivasure Medical offers us the chance to open up a new and exciting area of application for RESOMER®", says Jean-Luc Herbeaux, Head of Evonik’s Health Care Business Line.
Solvay to produce green hydrogen for its Peroxides activity in Rosignano, Italy
Partnership with Sapio will develop Europe's first hub for the production of green hydrogen peroxide by mid-2026 and help decarbonize the plant.
Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in Longlaville, France
Under the agreement Carbios should acquire 13ha land from Indorama Ventures’ existing PET plant at Longlaville and expects to be granted permits by Q3 2023, allowing start of construction by end of...
Plug power makes major strategic move into Finland’s green hydrogen economy with its proven PEM Electrolyzer and Liquefaction technology at Kokkola, Kristinestad and Porvoo
Plug plans to develop three green hydrogen production plants in Finland for European markets, working with multiple financial and industrial partners
ACC inaugurates its first Gigafactory in Billy-Berclau/Douvrin, France
This Gigafactory includes over 60,000 m2 of workshops, with an initial production line with a capacity of more than 13 GWh, rising to 40 GWh by 2030. A local, skilled workforce that will contribute...